Repros Therapeutics NASDAQ:RPRX, Enzymotec Ltd. NASDAQ:ENZY and Covisint Corp. NASDAQ:COVS are making big gains this Thursday. Voltari Corp. NASDAQ:VLTC, Xenon Pharmaceuticals Inc. NASDAQ:XENE and Scorpio Bulkers Inc. NYSE:SALT are posting losses. Sign up for our free newsletter Repros Therapeutics Climbs on FDA Application Approval Repros Therapeutics climbed +9.31% early in the day after announcing yesterday that the FDA has accepted its new drug application. Farallon Capital has a small stake in the biotech company. Enzymotec Ltd. rallied +7.34% this morning, though year-to-date its performance remains flat. John Paulson owns 4.24 million ENZY shares - 19.27% of the company. Covisint Corp. gained +7.14% this Thursday, though the stock is still down more than -20% year-to-date. Short interest in COVS is on the rise, and it hit a new 52-week low last month. This is another Farallon Capital pick. Voltari Corp. Dips Voltari Corp. dipped -7.6% this morning, though it's still up an incredible +182.5% over the past five days. The explanation: Carl Icahn's disclosure of what appears to be an activist stake in the firm. Xenon Pharmaceuticals tumbled -4.26% and is down -15% YTD. Wilbur Ross has a stake in the company. Scorpio Bulkers Inc. fell -4.07% early in the day, though it's still up about +7% in 2015. As of the end of the fourth quarter of last year, Marc Lasry holds 16.53 million SALT shares. The company has a 3.01% in his public equity portfolio. Voltari Corp. Dips After Icahn-Driven Surge appeared first on ValueWalk. Like this article? Sign up for our free newsletter to get articles delivered to your inbox -By iBillionaire
More from Stocks
Jim Cramer Takes a Look Ahead to the Federal Reserve Decision
Jim Cramer breaks down what to expect from today's Fed meeting and rates decision.
Federal Reserve, FedEx, Adobe, Facebook and Chewy - 5 Things You Must Know
U.S. stock futures fall modestly in cautious trading as investors focus on the Federal Reserve's interest rates decision expected later Wednesday; FedEx sinks after fiscal first-quarter earnings at the shipping giant miss analysts' forecasts and the company lowers its outlook for fiscal 2020; Adobe falls on weak fourth-quarter guidance; Facebook reportedly is working with Ray-Ban to develop augmented reality glasses.
Dow Futures Drift Lower, Global Markets Cautious Ahead of Fed Rate Decision
Global stocks traded cautiously Wednesday, with investors focused on both the U.S. Federal Reserve's September rate decision later today in Washington and the impact of last weekend's attacks on two key Saudi oil facilities on world crude markets.
Adobe Shares Slip After Soft Revenue Guidance Offsets Solid Q3 Earnings
Adobe slipped lower in pre-market trading Wednesday after the world's third-largest cloud software group forecast softer-than-expected fourth quarter revenues amid disappointing results from its recently-added marketing software division.